Novelstar R&D division is working on innovations and advanced pharmaceutical drug delivery systems, with a focus on new medicines (NDA), and high-quality generic products (ANDA). Our expertise across different delivery systems and technologies includes: Tablets, Capsules, Granules, Liquids, Semi-solids, Parenteral, Topical, Transdermal and Combination products, and Immediate Release and Modified Release systems. Our passion is to develop and deliver a valuable, cost effective pipeline of best-in-class products to consumers with safety and efficacy under Good Laboratory Practices (GLP), Current Good Manufacturing Practices (cGMP) and Good Clinical Practices (GCP) in near future.